These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 22350379)
1. Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma. Massimino M; Cefalo G; Riva D; Biassoni V; Spreafico F; Pecori E; Poggi G; Collini P; Pollo B; Valentini L; Potepan P; Seregni E; Casanova M; Ferrari A; Luksch R; Polastri D; Terenziani M; Pallotti F; Clerici CA; Schiavello E; Simonetti F; Meazza C; Catania S; Podda M; Gandola L J Neurooncol; 2012 May; 108(1):163-71. PubMed ID: 22350379 [TBL] [Abstract][Full Text] [Related]
2. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615 [TBL] [Abstract][Full Text] [Related]
3. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332 [TBL] [Abstract][Full Text] [Related]
4. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918 [TBL] [Abstract][Full Text] [Related]
5. Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study. Mosijczuk AD; Nigro MA; Thomas PR; Burger PC; Krischer JP; Morantz RA; Kurdunowicz B; Mulne AF; Towbin RB; Freeman AI Cancer; 1993 Nov; 72(9):2755-62. PubMed ID: 8402500 [TBL] [Abstract][Full Text] [Related]
6. Concomitant weekly vincristine and radiation followed by adjuvant vincristine and carboplatin in the treatment of high risk medulloblastoma: Ain Shams University Hospital and Sohag Cancer Center study. Salama MM; Ghorab EM; Al-Abyad AG; Al-Bahy KM J Egypt Natl Canc Inst; 2006 Jun; 18(2):167-74. PubMed ID: 17496943 [TBL] [Abstract][Full Text] [Related]
7. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy. Rutkauskiene G; Labanauskas L Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959 [TBL] [Abstract][Full Text] [Related]
8. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538 [TBL] [Abstract][Full Text] [Related]
10. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Goldwein JW; Radcliffe J; Johnson J; Moshang T; Packer RJ; Sutton LN; Rorke LB; D'Angio GJ Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):899-904. PubMed ID: 8598368 [TBL] [Abstract][Full Text] [Related]
11. Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan. Yamasaki K; Okada K; Soejima T; Sakamoto H; Hara J Pediatr Blood Cancer; 2020 Jan; 67(1):e28012. PubMed ID: 31544362 [TBL] [Abstract][Full Text] [Related]
12. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma. Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589 [TBL] [Abstract][Full Text] [Related]
13. Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy. Hartsell WF; Gajjar A; Heideman RL; Langston JA; Sanford RA; Walter A; Jones D; Chen G; Kun LE Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):15-24. PubMed ID: 9300735 [TBL] [Abstract][Full Text] [Related]
14. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. Taylor RE; Bailey CC; Robinson K; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Walker DA; Pizer BL; Imeson J; Lashford LS; ; J Clin Oncol; 2003 Apr; 21(8):1581-91. PubMed ID: 12697884 [TBL] [Abstract][Full Text] [Related]
15. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy. Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618 [TBL] [Abstract][Full Text] [Related]
16. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience. Khalil EM J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474 [TBL] [Abstract][Full Text] [Related]
17. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma. Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566 [TBL] [Abstract][Full Text] [Related]
18. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma. Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547 [TBL] [Abstract][Full Text] [Related]
19. CNS-85 trial: a cooperative pediatric CNS tumor study--results of treatment of medulloblastoma patients. Pezzotta S; Cordero di Montezemolo L; Knerich R; Arrigoni M; Barbara A; Besenzon L; Brach del Prever A; Fidani P; Locatelli D; Loiacono G; Magrassi L; Perilongo G; Rigobello L; Urgesi A; Madon E Childs Nerv Syst; 1996 Feb; 12(2):87-96. PubMed ID: 8674087 [TBL] [Abstract][Full Text] [Related]
20. The change in patterns of relapse in medulloblastoma. Tarbell NJ; Loeffler JS; Silver B; Lynch E; Lavally BL; Kupsky WJ; Scott RM; Sallan SE Cancer; 1991 Oct; 68(7):1600-4. PubMed ID: 1893359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]